Impact of Quinoa Milk Fermented With Lactic Acid Bacteria From Foods on Human Oral and Intestinal Flora

Sponsor
Lund University (Other)
Overall Status
Completed
CT.gov ID
NCT04280731
Collaborator
Swedish International Development Cooperation Agency (SIDA) (Other)
20
1
1
5.4
3.7

Study Details

Study Description

Brief Summary

The demand for alternatives to dairy products has increased in recent years and a lot of proposals for vegetable milk and yogurt products have taken place in the market. Quinoa is a plant from South America that has growth in popularity in recent years as many sought out nutritious and healthier eating, the herb is known for its high nutritional value. It is complete protein source containing all the essential amino acids. If this herb were fermented with probiotic bacteria, there is a potential for a product that is lactose free, gluten free and cholesterol free.

The probiotic potential of quinoa milk, fermented with food associated lactic acid bacteria will be investigated. This includes a study that examines how daily consumption of this vegetable drink changes the composition of the oral and intestinal flora. Therefore, healthy people are now seeking to participate in the study, which will be for just over 2 weeks.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: fermented quinoa
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Impact of Quinoa Milk Fermented With Lactic Acid Bacteria From Foods on Human Oral and Intestinal Flora
Actual Study Start Date :
Jan 7, 2020
Actual Primary Completion Date :
Jun 20, 2020
Actual Study Completion Date :
Jun 20, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Fermented drink

Dietary Supplement: fermented quinoa
Quinoa drink fermented with lactic acid bacteria isolated from food

Outcome Measures

Primary Outcome Measures

  1. Survivability of the lactic acid bacteria [2 weeks]

    If the bacteria can be isolated in a adequate amount by cultivation on MRS broth and rogosa agar

Secondary Outcome Measures

  1. Changes in the human microbiota [2 weeks]

    Changes in the saliva and stool samples by analyzes with Terminal Restriction Fragment Length polymorphism

  2. Changes in the human microbiota [2 weeks]

    Changes in the saliva and stool samples by quantitative polymorphic chain reaction

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Above 18 years and healthy volunteers
Exclusion Criteria:
  • Participants that have any kind of diseases, such as colon inflammation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kemicentrum Lund Skåne Sweden 223 62

Sponsors and Collaborators

  • Lund University
  • Swedish International Development Cooperation Agency (SIDA)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Åsa Håkansson, Principal Investigator, Lund University
ClinicalTrials.gov Identifier:
NCT04280731
Other Study ID Numbers:
  • FermCH
First Posted:
Feb 21, 2020
Last Update Posted:
Oct 5, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2020